Investigation of Chlamydia trachomatis-specific IgA, IgG Antibody with EIA Method.
スポンサーリンク
概要
- 論文の詳細を見る
Recently, two new kits, HITAZYME (Hitachi Chemical Co., Ltd.) and SERO IPALISA (Savyon Diagnostics, Ltd.), for the assay of and-<I>C.trachomatis</I> antibodies by the enzyme immunoassay (EIA) method have been developed and put into clinical application.<BR>In the study reported here, the authors investigated the clinical usefulness of these assay kits, together with the IPAzyme and micro-IF test, in the diagnosis of cases of urogenital tract <I>C.tachomatis</I> infections.<BR>1.The positive rates for IgA antibodies, which are considered to be an indicator of active infection, obtained with the HITAZYME and SERO IPALISA kits in the 82 antigen-positive cases were significantly (p<0.005) higher than the rates obtained with the IPAzyme and micro-IF test.These results showed the usefulness of the HITAZYME and SERO IPALISA kits for detecting <I>C.trachomatis</I> infections.<BR>2.A comparison was made of the assay results obtained with the HITAZYME and SERO IPALISA kits, and it was found that there was a large number of cases (142) that tested negative for IgA antibodies with the HITAZYME but positive with the SERO IPALISA kit.We carried out a confirmatory test on the specimens of cases for which the results obtained with the HITAZYME and SERO IPALISA kits were not in agreement.This test employed the Western blotting method using COMC (the antigen extracted from EB of <I>C.trachomatis</I> strain L<SUB>2</SUB> and used in the HITAZYME kit) and whole EB of <I>C.trachomatis</I> strain L<SUB>2</SUB> (the antigen used in the SERO IPALISA kit).The results showed a significantly higher degree of agreement between the HITAZYME kit data and the Western blotting data than between the SERO IPALISA kit data and the Western blotting data.<BR>3.In addition, with the objective of investigating the existence of cross reactivity with anti-<I>C. pneumoniae</I> antibodies, we performed Western blotting using as the antigen crude whole EB of <I>C. pneumoniae</I> strain TW-183.The results showed that anti-<I>C.pneumoniae</I> antibodies were detected in 25 of 35 (71.4%) cases that were negative with <I>C.trachomatis</I> antigen and the HITAZYME kit and positive with the SERO IPALISA kit.These findings indicate a strong possibility that these cases positive with the SERO IPALISA kit are due to a cross reaction with anti-<I>C.pneumoniae</I> antibodies.<BR>It is concluded that the HITAZYME kit is an excellent tool for detecting anti-<I>C.trachomatis</I> antibodies since it present various advantages: high specificity for and-<I>C.trachomatis</I> antibodies, a high degree of objectivity since it employs an EIA method based on evaluation of the absorbance, a simple procedure, and can handle a large number of specimens, etc.<BR>The HITAZYME kit can be used when antigen tests are difficult to perform.It is strongly anticipated that it can be used clinically as a screening test.
- The Japanese Association for Infectious Diseasesの論文
The Japanese Association for Infectious Diseases | 論文
- Simple Method for Typing Human Immunodeficiency Virus Type 1 (B, E) by PCR and Chronological Change of Distribution ofSubtype (B to E) in Japan.
- Kinetic Analysis of Anti-HIV Titer in Early Stage of HIV Infection. A New Testing Strategy to Differentiate Early HIV Infection Individuals from False Positive Cases.:A New Testing Strategy to Differentiate Early HIV Infection Individuals from False Posit
- HIV-1 (Human Immunodeficiency Virus Type 1) Mutant Strain Associated with Zidovudine Resistance Detected from a Japanese Patient with Primary HIV-1 Infection.
- Epidemiological and Bacteriological Study on Gonococcal Infections.
- A Case of Trichosporon beigelii Peritonitis in CAPD.